[{"id":"4055a93d-2131-4f4e-8005-5f87a9fc5ccd","acronym":"","url":"https://clinicaltrials.gov/study/NCT00728793","created_at":"2021-01-18T02:44:38.497Z","updated_at":"2024-07-02T16:37:13.734Z","phase":"Phase 1","brief_title":"A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT00728793","lead_sponsor":"Curis, Inc.","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CUDC-101"],"overall_status":"Completed","enrollment":" Enrollment 25","initiation":"Initiation: 08/01/2008","start_date":" 08/01/2008","primary_txt":" Primary completion: 04/01/2010","primary_completion_date":" 04/01/2010","study_txt":" Completion: 04/01/2010","study_completion_date":" 04/01/2010","last_update_posted":"2018-02-22"}]